RAS: Past, Present, and Future - Humanitas

RAS: Past, Present, and Future

Voted 0
ISBN: 9780128244852
Published: 2022
Publisher: Academic Press
Language: English
Format: Hardback
Format: 9×6
Description
<i>Advances in Cancer Research, volume 153</i> provides a timely review of the biology, biochemistry, and current approaches to therapeutically target the RAS oncoprotein, the most frequently mutated oncogene family in human cancers. 2021 saw the approval of the first direct RAS inhibitor (sotorasib) for use in treating non-small cell lung cancers harboring KRAS(G12C) mutations. The successful approval and use of this drug highlights that the once “undruggable” RAS is indeed pharmacologically tractable. This volume provides an overview of efforts to develop additional approaches to therapeutically target oncogenic RAS. In addition, the reader will find excellent reviews on the history and research efforts to understand the biochemistry and oncogenic activity of RAS in human cancers.

Reviews (0)
Write a review